Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11139)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2015 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu JZ, Zhou QY, Wang YM, Dai YN, Zhu J, Yu CH, Li YM. Prevalence of fatty liver disease and the economy in China: A systematic review. World J Gastroenterol 2015; 21(18): 5695-5706 [PMID: 25987797 DOI: 10.3748/wjg.v21.i18.5695] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i18/5695.htm |
| Number | Citing Articles |
| 1 |
Jinzhou Zhu, Mingqing He, Yong Zhang, Tingxin Li, Yuping Liu, Zhiye Xu, Weichang Chen. Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study. Endocrine Journal 2018; 65(3): 373 doi: 10.1507/endocrj.EJ17-0466
|
| 2 |
Feng Zhou, Jianghua Zhou, Wenxin Wang, Xiao‐Jing Zhang, Yan‐Xiao Ji, Peng Zhang, Zhi‐Gang She, Lihua Zhu, Jingjing Cai, Hongliang Li. Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis. Hepatology 2019; 70(4): 1119 doi: 10.1002/hep.30702
|
| 3 |
梦昆 李. Correlation Analysis of LIPA rs1051338 and Risk of Non-Alcoholic Fatty Liver Disease in Chinese Han Population. Advances in Clinical Medicine 2024; 14(05): 1891 doi: 10.12677/acm.2024.1451631
|
| 4 |
Xiao-Hui Fang, Cai-E Wang, Jiao Deng, Xing-Shun Qi. Statins for treatment of fatty liver disease: Recent advances. World Chinese Journal of Digestology 2023; 31(16): 659 doi: 10.11569/wcjd.v31.i16.659
|
| 5 |
Ying-ying Yu, Yu-ling Tong, Ling-yan Wu, Xin-yan Yu. Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23746-0
|
| 6 |
Xia Fang, Hongya Wang, Ting Ye, Xiaolan Fu, Xiaozhen Tan, Yan Zeng, Jiahao Fan, Yong Xu. Low serum Maresin-1 levels are associated with non-alcoholic fatty liver disease: a cross-sectional study. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01518-5
|
| 7 |
Yadi Li, Yan Yang, Yufang Li, Ping Zhang, Gaiying Ge, Jing Jin, Ting Du, Maiyan Ma, Li Na, Lu Ding, Huiping Sheng. Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis. Journal of International Medical Research 2021; 49(11) doi: 10.1177/03000605211055378
|
| 8 |
Jin-Zhou Zhu, Hua-Tuo Zhu, Yi-Ning Dai, Chun-Xiao Li, Zhi-Yun Fang, De-Jian Zhao, Xing-Yong Wan, Yu-Ming Wang, Fang Wang, Chao-Hui Yu, You-Ming Li. Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case–control study. Endocrine 2016; 51(1): 91 doi: 10.1007/s12020-015-0735-2
|
| 9 |
Nannan Gao, Yong Yu, Bingchang Zhang, Zhongshang Yuan, Haiqing Zhang, Yongfeng Song, Meng Zhao, Jiadong Ji, Lu Liu, Chao Xu, Jiajun Zhao. Dyslipidemia in rural areas of North China: prevalence, characteristics, and predictive value. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0328-y
|
| 10 |
Lin Guan, Xinhe Zhang, Haoyu Tian, Xing Jin, Hang Fan, Ningning Wang, Jing Sun, Dan Li, Jia Li, Xue Wang, Zilu Zeng, Yiling Li. Prevalence and risk factors of metabolic-associated fatty liver disease during 2014–2018 from three cities of Liaoning Province: an epidemiological survey. BMJ Open 2022; 12(2): e047588 doi: 10.1136/bmjopen-2020-047588
|
| 11 |
Mengmeng Hou, Qi Gu, Jiawei Cui, Yao Dou, Xiuhong Huang, Jie Li, Liang Qiao, Yuemin Nan. Proportion and clinical characteristics of metabolic-associated fatty liver disease and associated liver fibrosis in an urban Chinese population. Chinese Medical Journal 2024; doi: 10.1097/CM9.0000000000003141
|
| 12 |
Ya-Ping Huang, Shi Zhang, Minying Zhang, Yi Wang, Wen-Hong Wang, Jing Li, Chunjun Li, Jing-Na Lin. Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study. BMJ Open 2021; 11(12): e056260 doi: 10.1136/bmjopen-2021-056260
|
| 13 |
Dandan Sheng, Shanmin Zhao, Lu Gao, Huifei Zheng, Wenting Liu, Jing Hou, Yuxiang Jin, Fei Ye, Qiudong Zhao, Rong Li, Naping Zhao, Li Zhang, Zhipeng Han, Lixin Wei. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling. Cell & Bioscience 2019; 9(1) doi: 10.1186/s13578-019-0339-2
|
| 14 |
Mingmei Shao, Yifei Lu, Hongjiao Xiang, Junmin Wang, Guang Ji, Tao Wu. Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.971561
|
| 15 |
Zi-yuan Dong, Bing-Jie Xiang, Min Jiang, Ming-jun Sun, Cong Dai. The Prevalence of Gastrointestinal Symptoms, Abnormal Liver Function, Digestive System Disease and Liver Disease in COVID-19 Infection. Journal of Clinical Gastroenterology 2021; 55(1): 67 doi: 10.1097/MCG.0000000000001424
|
| 16 |
Minghe Wang, Xuejing Wang, Yanqi Wang, Yikuo Gai, Jingran Ye, Xinyan Xu, Xue You. Advances in the study of the mechanism of action of miR‑22 in liver lesions (Review). Oncology Letters 2024; 28(5) doi: 10.3892/ol.2024.14674
|
| 17 |
Youdong Li, Jinwei Li, Peirang Cao, Yuanfa Liu. Sinapine-enriched rapeseed oils reduced fatty liver formation in high-fat diet-fed C57BL/6J mice. RSC Advances 2020; 10(36): 21248 doi: 10.1039/D0RA00215A
|
| 18 |
Jia Xiao, Fei Wang, Nai-Kei Wong, Jinhan He, Rui Zhang, Ruijuan Sun, Yanying Xu, Yingxia Liu, Wei Li, Kazuo Koike, Weiling He, Hong You, Yinglei Miao, Xiaowei Liu, Mingming Meng, Bin Gao, Hua Wang, Cui Li. Global liver disease burdens and research trends: Analysis from a Chinese perspective. Journal of Hepatology 2019; 71(1): 212 doi: 10.1016/j.jhep.2019.03.004
|
| 19 |
TengFei Yang, Bo Zhao, Dongmei Pei. Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3437 doi: 10.2147/DMSO.S320808
|
| 20 |
Xiaohui Zhang, Yizhi Zhang, Wen Gao, Zhihao Guo, Kun Wang, Shuang Liu, Zhongping Duan, Yu Chen. Naringin improves lipid metabolism in a tissue-engineered liver model of NAFLD and the underlying mechanisms. Life Sciences 2021; 277: 119487 doi: 10.1016/j.lfs.2021.119487
|
| 21 |
Jun ZHU, Dujuan XU, Ruihua YANG, Min LIU, Ying LIU. The triglyceride glucose index and CDKAL1 gene rs10946398 SNP are associated with NAFLD in Chinese adults. Minerva Endocrinology 2023; 48(1) doi: 10.23736/S2724-6507.20.03273-3
|
| 22 |
Qiuyue Ma, Fude Yang, Botao Ma, Wenzhan Jing, Jue Liu, Moning Guo, Juan Li, Zhiren Wang, Min Liu. Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study. Hepatology International 2021; 15(1): 127 doi: 10.1007/s12072-020-10132-z
|
| 23 |
Yu Ji, Kenneth Elkin, James Yip, Longfei Guan, Wei Han, Yuchuan Ding. From circadian clocks to non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019; 13(11): 1107 doi: 10.1080/17474124.2019.1684899
|
| 24 |
Jia-Zhen ZHU, Hong-Wei YI, Wei HUANG, Tao PANG, Hui-Ping ZHOU, Xu-Dong WU. Fatty liver diseases, mechanisms, and potential therapeutic plant medicines. Chinese Journal of Natural Medicines 2020; 18(3): 161 doi: 10.1016/S1875-5364(20)30017-0
|
| 25 |
Wei-Kei Wong, Wah-Kheong Chan. Nonalcoholic Fatty Liver Disease: A Global Perspective. Clinical Therapeutics 2021; 43(3): 473 doi: 10.1016/j.clinthera.2021.01.007
|
| 26 |
Dacheng Wu, Min Zhang, Songxin Xu, Keyan Wu, Ningzhi Wang, Yuanzhi Wang, Jian Wu, Guotao Lu, Weijuan Gong, Yanbing Ding, Weiming Xiao. Nonalcoholic Fatty Liver Disease Aggravated the Severity of Acute Pancreatitis in Patients. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/9583790
|
| 27 |
Rui Li, Hang Li, Xujun Ye, Juanjuan Qin. Metabolic Dysfunction-associated Steatotic Liver Disease is Becoming the Leading Driver of the Burden of Cirrhosis in China. Journal of Clinical Gastroenterology 2024; doi: 10.1097/MCG.0000000000002055
|
| 28 |
Weiwei He, Yinxiang Huang, Xiulin Shi, Qingxuan Wang, Menghua Wu, Han Li, Qiuhong Liu, Xiaofang Zhang, Caoxin Huang, Xuejun Li. Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04300-6
|
| 29 |
Qiang Zeng, Zhenya Song, Yi Zhao, Jianjun Wu, Liuhong Wang, Huiyi Ye, Yingwei Wang, Ting Wu, Sishu Yuan, Haojie Yuan. Controlled attenuation parameter by vibration‐controlled transient elastography for steatosis assessment in members of the public undergoing regular health checkups with reference to magnetic resonance imaging‐based proton density fat fraction. Hepatology Research 2020; 50(5): 578 doi: 10.1111/hepr.13481
|
| 30 |
M. León-Plascencia, A. Larrosa-Haro, E. Romero-Velarde, E.C. Bravo-Núñez, E. López-Marure. Factores alimenticios y sociodemográficos asociados con el hígado graso no alcohólico en pacientes pediátricos obesos. Revista de Gastroenterología de México 2021; 86(3): 236 doi: 10.1016/j.rgmx.2020.06.011
|
| 31 |
Chang-Gue Son. A juvenile case with nonalcoholic steatohepatitis and traditional Korean medicine-based treatment. Integrative Medicine Research 2018; 7(2): 206 doi: 10.1016/j.imr.2018.01.006
|
| 32 |
Ting Bao, Zhiye Ying, Li Gong, Jing Du, Guiyi Ji, Zhengzheng Li, Wei Gao, Xianweng Jiang, Hanwei Yang, Yan Huang, Huairong Tang. Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Nonobese Postmenopausal Women: A Cross-sectional Study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66931-9
|
| 33 |
Wei He, Jin Xu, Xiang Wang, Zhining Fan, Hai Li. Macrophage-derived exosomal miR-155 regulating hepatocyte pyroptosis in MAFLD. Heliyon 2024; 10(15): e35197 doi: 10.1016/j.heliyon.2024.e35197
|
| 34 |
Hui Wang, Qian Gao, Simin He, Yanping Bao, Hongwei Sun, Lingxian Meng, Jie Liang, Chenming Sun, Shuohua Chen, Liying Cao, Wei Huang, Yanmin Zhang, Jianjun Huang, Shouling Wu, Tong Wang. Self-reported snoring is associated with nonalcoholic fatty liver disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66208-1
|
| 35 |
Bingqian Zhou, Ni Gong, Qingnan He, Xinjuan Huang, Jingchi Zhu, Lijun Zhang, Yanyan Huang, Xinyun Tan, Yuanqin Xia, Yu Zheng, Qiuling Shi, Chunxiang Qin. Clustering of lifestyle behaviours and analysis of their associations with MAFLD: a cross-sectional study of 196,515 individuals in China. BMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-17177-3
|
| 36 |
Jian Gao Fan, Lai Wei, Hui Zhuang. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). Journal of Digestive Diseases 2019; 20(4): 163 doi: 10.1111/1751-2980.12685
|
| 37 |
Hong Pan, Baocheng Liu, Xin Luo, Xinxin Shen, Jijia Sun, An Zhang. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01966-1
|
| 38 |
Ting Hong, Yiyan Chen, Xiaoying Li, Yan Lu, Jun Pu. The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/6889533
|
| 39 |
Wai-Kay Seto, Man-Fung Yuen. Nonalcoholic fatty liver disease in Asia: emerging perspectives. Journal of Gastroenterology 2017; 52(2): 164 doi: 10.1007/s00535-016-1264-3
|
| 40 |
Tongtong Li, Trudy Lei, Zheng Xie, Tuohong Zhang. Determinants of basic public health services provision by village doctors in China: using non-communicable diseases management as an example. BMC Health Services Research 2015; 16(1) doi: 10.1186/s12913-016-1276-y
|
| 41 |
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
|
| 42 |
Xiuying Zhang, Xianghai Zhou, Xueyao Han, Zuodi Fu, Lianying Wang, Yufeng Li, Linong Ji. The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population. Metabolic Syndrome and Related Disorders 2020; 18(6): 284 doi: 10.1089/met.2019.0107
|
| 43 |
M. León-Plascencia, A. Larrosa-Haro, E. Romero-Velarde, E.C. Bravo-Núñez, E. López-Marure. Dietary and sociodemographic factors associated with nonalcoholic fatty liver in obese pediatric patients. Revista de Gastroenterología de México (English Edition) 2021; 86(3): 236 doi: 10.1016/j.rgmxen.2021.05.005
|
| 44 |
Rui Fan, Jufang Wang, Jinman Du. Association between body mass index and fatty liver risk: A dose-response analysis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33419-6
|
| 45 |
Huei-Wen Lim, David E. Bernstein. Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics. Clinics in Liver Disease 2018; 22(1): 39 doi: 10.1016/j.cld.2017.08.008
|
| 46 |
Youdong Li, Liang Zhang, Yong-Jiang Xu, Jinwei Li, Peirang Cao, Yuanfa Liu. Evaluation of the functional quality of rapeseed oil obtained by different extraction processes in a Sprague-Dawley rat model. Food & Function 2019; 10(10): 6503 doi: 10.1039/C9FO01592B
|
| 47 |
Chao Li, Jie Yang, Yu Wang, Yingzi Qi, Wenqing Yang, Yunlun Li. Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01247
|
| 48 |
Ming Xie, Haokai Tang, Feifei Li, Si Wu, Yanhui Dong, Yide Yang, Julien Steven Baker, Jun Ma. Mediating Roles of hsCRP, TNF-α and Adiponectin on the Associations between Body Fat and Fatty Liver Disease among Overweight and Obese Adults. Biology 2021; 10(9): 895 doi: 10.3390/biology10090895
|
| 49 |
Zheng Yao, Jia Guo, Bing Du, Li Hong, Ying Zhu, Xiaoyi Feng, Yuanlu Hou, Anhua Shi. Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1147067
|
| 50 |
Ying-Li Liu, Qiu-Zan Zhang, Yan-Rong Wang, Li-Na Fu, Jing-Shu Han, Jing Zhang, Bang-Mao Wang. Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.605064
|
| 51 |
Li Han, Yuting Zhang, Cui Yue, Yiqin Huang, Yumin Wu, Jie Chen, Rahim Khan. Preliminary Study on Risk Factors for Morbidity of Nonalcoholic Fatty Liver Disease in High-Income Male Population. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/9331284
|